These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32158198)

  • 1. Contribution of Trough Concentration Data in the Evaluation of Multiple-Dose Pharmacokinetics for Drugs with Delayed Distributional Equilibrium and Long Half-Life.
    Choi S; Jeon S; Yim DS; Han S
    Drug Des Devel Ther; 2020; 14():811-821. PubMed ID: 32158198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modeling and simulation activities to design sampling scheme for population pharmacokinetic study on amlodipine].
    Zuo XC; Yuan H; Zhang BK; Ng CM; Barrett JS; Yang GP; Huang ZJ; Pei Q; Guo R; Zhou YN; Jing NN; Di W
    Yao Xue Xue Bao; 2012 Jul; 47(7):941-6. PubMed ID: 22993862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulation for clinical repeated-dose pharmacokinetic trials applying a peak-and-trough sampling design to estimate oral clearance.
    Ishida K; Kayano Y; Taguchi M; Hashimoto Y
    Biol Pharm Bull; 2007 Nov; 30(11):2159-62. PubMed ID: 17978492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of multiple-trough sampling design and algorithm on the estimation of population and individual pharmacokinetic parameters].
    Ling J; Qian LX; Ding JJ; Jiao Z
    Yao Xue Xue Bao; 2014 May; 49(5):686-94. PubMed ID: 25151742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic profiles of a fixed-dose combination of olmesartan medoxomil and amlodipine in healthy Chinese males and females.
    Chen X; Hu P; Jiang J; Liu T; Zhong W; Liu H; Zhao Q
    Clin Drug Investig; 2012 Dec; 32(12):783-90. PubMed ID: 23160920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crossover comparison of the pharmacokinetics of amlodipine and felodipine ER in hypertensive patients.
    Videbaek LM; Jacobsen IA
    Int J Clin Pharmacol Ther; 1997 Nov; 35(11):514-8. PubMed ID: 9401833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
    Wilhelm AJ; de Graaf P; Veldkamp AI; Janssen JJ; Huijgens PC; Swart EL
    Br J Clin Pharmacol; 2012 Apr; 73(4):553-63. PubMed ID: 21988410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional half-life is a meaningful descriptor of steady-state pharmacokinetics of an extended-release formulation of a rapidly cleared drug : as shown by once-daily divalproex-ER.
    Dutta S; Reed RC
    Clin Drug Investig; 2006; 26(12):681-90. PubMed ID: 17274675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic evaluation with external validation and Bayesian estimator of voriconazole in liver transplant recipients.
    Han K; Bies R; Johnson H; Capitano B; Venkataramanan R
    Clin Pharmacokinet; 2011 Mar; 50(3):201-14. PubMed ID: 21294597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of single and multiple oral doses of valsartan/amlodipine (80/5 mg) in healthy Chinese subjects.
    Duan J; Chen J; Yin Q; Karan R; Meiser K; Smith HT; Sunkara G
    Int J Clin Pharmacol Ther; 2012 Jan; 50(1):33-43. PubMed ID: 22192643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional notes on clinical repeated-dose pharmacokinetic trials applying a peak-and-trough sampling design to estimate oral clearance.
    Takaai M; Kayano Y; Shimizu T; Taguchi M; Hashimoto Y
    Drug Metab Pharmacokinet; 2008; 23(2):128-33. PubMed ID: 18445993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetically based estimation of patient compliance with oral anticancer chemotherapies: in silico evaluation.
    Hénin E; Tod M; Trillet-Lenoir V; Rioufol C; Tranchand B; Girard P
    Clin Pharmacokinet; 2009; 48(6):359-69. PubMed ID: 19650675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levels.
    Gotta V; Widmer N; Montemurro M; Leyvraz S; Haouala A; Decosterd LA; Csajka C; Buclin T
    Clin Pharmacokinet; 2012 Mar; 51(3):187-201. PubMed ID: 22339450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations in analyzing single-trough concentrations using mixed-effects modeling.
    Booth BP; Gobburu JV
    J Clin Pharmacol; 2003 Dec; 43(12):1307-15. PubMed ID: 14615466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic simulations of topiramate plasma concentrations following dosing irregularities with extended-release vs. immediate-release formulations.
    Brittain ST; Wheless JW
    Epilepsy Behav; 2015 Nov; 52(Pt A):31-6. PubMed ID: 26409125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open study of tolerability and pharmacokinetics of raclopride extended release capsules in psychiatric patients: a Canadian study.
    Gendron A; Sirois G; Nair NP; Bloom D; Movin-Osswald G; Uppfeldt G
    J Psychiatry Neurosci; 1995 Jul; 20(4):287-96. PubMed ID: 7647082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the performance of first-order conditional estimation (FOCE) and different expectation-maximization (EM) methods in NONMEM: real data experience with complex nonlinear parent-metabolite pharmacokinetic model.
    Bach T; An G
    J Pharmacokinet Pharmacodyn; 2021 Aug; 48(4):581-595. PubMed ID: 33884580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The operational multiple dosing half-life: a key to defining drug accumulation in patients and to designing extended release dosage forms.
    Sahin S; Benet LZ
    Pharm Res; 2008 Dec; 25(12):2869-77. PubMed ID: 19015955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.